Amneal Pharmaceuticals, Inc. provided earnings guidance for the full year of 2022. For the year, the company expects net revenue to be between $2.15 billion to $2.25 billion.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.47 USD | -0.46% |
|
-3.72% | +6.59% |
![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+6.59% | 2B | |
+54.61% | 811B | |
+43.62% | 640B | |
-6.33% | 353B | |
+20.62% | 333B | |
+10.44% | 302B | |
+17.94% | 246B | |
+2.54% | 225B | |
+12.68% | 218B | |
+8.61% | 168B |
- Stock Market
- Equities
- AMRX Stock
- News Amneal Pharmaceuticals, Inc.
- Amneal Pharmaceuticals, Inc. Provides Earnings Guidance for the Full Year of 2022